Emory University School of Medicine
Emory University School of Medicine
Hematology and Medical Oncology

Hematology and Medical Oncology section navigation

Hematology and Medical Oncology

Profile

Mehmet Bilen MD

  • Department of Hematology and Medical Oncology
    Associate Professor
  • Winship Cancer Institute of Emory University
    1365B Clifton Rd NE, Suite B400, Office 4212
Head shot of Mehmet Bilen

Overview

A board certified medical oncologist, Dr. Bilen is actively involved in clinical research and patient care in the area of genitourinary cancers. He serves as director of the Genitourinary Medical Oncology Program at Winship Cancer Institute of Emory University. He works closely with the Fellowship Program of the Department of Hematology and Medical Oncology by educating fellows on genitourinary oncology. He also serves on the Winship Clinical and Translational Review Committee.

Dr. Bilen is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He holds professional memberships with American Association for Cancer Research and American Society of Clinical Oncology.

Dr. Bilen received his MD from Hacettepe University Faculty of Medicine in Ankara, Turkey. He completed a postdoctoral fellowship in Molecular Pathology and a clinical fellowship in Hematology/Oncology at UT MD Anderson Cancer Center in Houston, Texas. His postgraduate medical education also included residency training at Baylor College of Medicine in Houston, Texas.

As a postdoctoral fellow at UT MD Anderson Cancer Center, Dr. Bilen worked with Dr. Sue-Hwa Lin on developing biomarkers and therapeutic strategies that can be applied in clinical settings to promote early detection and to improve treatment options for prostate cancer bone metastasis. He focused on the role of cadherin-11 in prostate cancer bone metastasis and generating monoclonal antibodies that inhibited that metastasis. He showed that inhibition of cell adhesion by a cadherin-11 antibody thwarts prostate cancer bone metastasis and monotherapy using a cadherin-11 antibody is a suitable option for prevention.

Dr. Bilen continued to focus on genitourinary malignancies after becoming a clinical fellow at UT MD Anderson Cancer Center where he worked on several projects in clinical and translational research. In 2015, he was selected to participate in the AACR/ASCO Vail workshop.

Dr. Bilen has published a number of peer-reviewed original papers and reviews in leading journals including Cancer Research, Molecular Cancer Research, FASEB J, Journal of Pathology, Cancer and Clinical and Experimental Metastasis and has authored or co-authored several abstracts for presentations at professional meetings.

Academic Appointment

  • Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from Hacettepe University, Ankara

Research

Publications

Read more publications